European Archives - Page 1522 of 1528 - European Medical Journal

New Cervical Cancer Screening Guidelines on Both Sides of the Atlantic

Large population-based trials showed that the human papillomavirus (HPV) DNA test can be even more effective than Pap tests in preventing cervical cancer.

Intensity-Modulated Radiotherapy in the Treatment of Pancreatic Adenocarcinoma: A Review

Pancreatic cancer remains one of the leading causes of cancer deaths. Despite improvements in imaging, surgical techniques, chemotherapy agents, and…

Key Advances in the Systemic Therapy for Soft Tissue Sarcomas: Current Status and Future Directions

Soft tissue sarcomas (STS) represent a heterogeneous group of diverse neoplasms of mesenchymal origin. Once relapsed from standard therapy, STS patients…

Yoga as Treatment for Insomnia Among Cancer Patients and Survivors: A Systematic Review

Between 15-90% of cancer patients and survivors report some form of insomnia or sleep quality impairment during and post-treatment, such as excessive…

New Insights into the Definitive Management of Venous Thromboembolism

This educational symposium, supported by an unrestricted educational grant from Daiichi Sankyo, was given at the European Society of Cardiology (ESC)…

EMJ Cardiology 2013

Welcome to the inaugural edition of the European Medical Journal – Diabetes, which hosts in depth commentary from the 49th Annual Meeting of the European…

Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions

The current management of patients with hypertension, especially those with a high risk of coronary artery disease should take into account the role of…

The Changing Landscape in Oral Anticoagulation - The Last Pieces of the Puzzle

Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…

Practical Guidance for Stroke Prevention in Atrial Fibrillation – Interactive Case Studies

This Boehringer Ingelheim sponsored satellite symposium was held on 2nd September 2013 as part of the ESC conference, which was hosted this year in…

Managing Thromboembolic Risks of Atrial Fibrillation: Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices?

Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…